Dr. Kayalvizhi Sambandam, MD

Dr. Sambandam practices at Memorial Medical Center in Modesto, California, part of Sutter Health.

Dr. Sambandam's NPI, 1801820014, was assigned on July 11, 2006. Dr. Sambandam holds California license C53603.

Dr. Sambandam's primary practice is Memorial Medical Center, at 1700 Coffee Rd, Modesto, CA 95355 in Stanislaus County. The practice phone is (209) 526-4500.

Dr. Sambandam's primary practice is Memorial Medical Center in Modesto, California, part of Sutter Health. Dr. Sambandam is also affiliated with Memorial Hospital Los Banos. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Sambandam to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sambandam practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Sambandam's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Sambandam is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sambandam's licenses on file in 4 states: California, Pennsylvania, New Jersey and New York.

Dmand AI lists chronic obstructive pulmonary disease (COPD), chronic respiratory failure and tobacco use among the conditions Dr. Sambandam treats.

CMS data shows 493 Medicare services from Dr. Sambandam across 2 procedure codes in 2024, for 216 Medicare patients. Medicare paid $72,581 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 216 Medicare patients who saw Dr. Sambandam in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 50% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sambandam's median patient age at 60, with 44% women.

In 2019, Dr. Sambandam wrote 31 Medicare Part D claims. They cover 2 drugs, with $6,476 in total drug cost. In 2018, CMS named 127 claims across 6 drugs.

Dr. Sambandam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sambandam as offering telehealth.

CMS Open Payments shows 18 general payments to Dr. Sambandam from 4 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $314.

Dr. Sambandam is in network with 14 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.